AGM Statement
April 27 2007 - 6:42AM
UK Regulatory
RNS Number:6450V
Tepnel Life Sciences PLC
27 April 2007
27 April 2007
Tepnel Life Sciences plc ('Tepnel' or the 'Company')
Notice of AGM
Manchester, UK. 27 April 2007, Tepnel Life Sciences plc (AIM: TED) is pleased to
announce that its AGM is to be held at 10:00am on the 3rd May 2007 at Seymour
Pierce Ltd, Bucklersbury House, 3 Queen Victoria St, London EC4N 8EL.
- ends -
For Further Information:
Tepnel Life Sciences plc
Ben Matzilevich, CEO
Carol Smith
Tel: + 44 (0)161 946 2200
Capital MS&L
Mary Clark or Halina Kukula
Tel: +44 (0) 20 7307 5330
Email: mary.clark@capitalmsl.com
Notes to Editors
About Tepnel Life Sciences plc
Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services group with two divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 195 employees. TLS provides test
kits, reagents and services to two highly synergistic markets, these being
Molecular Diagnostics and Biomedical Research. The company's strategy has been
to identify high growth niche opportunities within these multi-billion pound
markets. TLS focuses on these niche opportunities with internally developed
products, patents, expertise and know-how as well as strategic acquisitions, to
develop a leadership position within these defined market segments.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMSESFSWSWSELL
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024